The Incidence and Risk Factors of Infusion-Related Reactions to Rituximab for Treating B Cell Malignancies in a Single Tertiary Hospital

Publisher: Karger

E-ISSN: 1423-0232|86|3|127-134

ISSN: 0030-2414

Source: Oncology, Vol.86, Iss.3, 2014-01, pp. : 127-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract